<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title>Molecular Vision</journal-title><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">a46</article-id><article-id pub-id-type="publisher-id">2006MOLVIS</article-id><article-id pub-id-type="pmid">17417604</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Cloning and characterization of canine <italic>PAX6</italic> and evaluation as a candidate gene in a canine model of aniridia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hunter</surname><given-names>Linda S.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sidjanin</surname><given-names>Duska J.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hijar</surname><given-names>Manuel Villagrasa</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Johnson</surname><given-names>Jennifer L.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kirkness</surname><given-names>Ewen</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Acland</surname><given-names>Gregory M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Aguirre</surname><given-names>Gustavo D.</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><aff id="aff1"><label>1</label>J.A. Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY</aff><aff id="aff2"><label>2</label>Department of Ophthalmology, The Medical College of Wisconsin, Milwaukee WI</aff><aff id="aff3"><label>3</label>The Veterinary Ophthalmology Center, Madrid, Spain</aff><aff id="aff4"><label>4</label>The Institute for Genomic Research, Rockville, MD</aff><aff id="aff5"><label>5</label>Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Gustavo Aguirre, VMD, PhD., Department of Clinical Studies-Philadelphia, School of Veterinary Medicine, University of Pennsylvania, 3900 Delancey Street, Philadelphia, PA, 19104-6010; Phone: (215) 898-4667; FAX: (215) 573-2162; email: <email xlink:href="gda@vet.upenn.edu">gda@vet.upenn.edu</email></corresp></author-notes><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>26</day><month>3</month><year>2007</year></pub-date><volume>13</volume><fpage>431</fpage><lpage>442</lpage><history><date date-type="received"><day>30</day><month>11</month><year>2006</year></date><date date-type="accepted"><day>21</day><month>3</month><year>2007</year></date></history><permissions><copyright-year>2007</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title>Purpose</title><p>Mutations in <italic>PAX6</italic> cause human aniridia. The <italic>small eye</italic> (<italic>sey</italic>) mouse represents an animal model for aniridia. However, no large animal model currently exists. We cloned and characterized canine <italic>PAX6</italic>, and evaluated <italic>PAX6</italic> for causal associations with inherited aniridia in dogs.</p></sec><sec sec-type="methods"><title>Methods</title><p>Canine <italic>PAX6</italic> was cloned from a canine retinal cDNA library using primers designed from human and mouse <italic>PAX6</italic> consensus sequences. An RH3000 radiation hybrid panel was used to localize <italic>PAX6</italic> within the canine genome. Genomic DNA was extracted from whole blood of dogs with inherited aniridia, and association testing was performed using markers on CFA18. Fourteen <italic>PAX6</italic> exons were sequenced and scanned for mutations, and a Southern blot was used to test for large deletions.</p></sec><sec><title>Results</title><p>Like the human gene, canine <italic>PAX6</italic> has 13 exons and 12 introns, plus an alternatively spliced exon (5a). <italic>PAX6</italic> nucleotide and amino acid sequences were highly conserved between dog, human, and mouse. The canine <italic>PAX6</italic> cDNA sequence determined in this study spans 2 large gaps present in the current canine genomic sequence. Radiation hybrid mapping placed canine <italic>PAX6</italic> on CFA18 in a region with synteny to HSA11p13. Exon-scanning revealed single nucleotide polymorphisms, but no pathological mutations, and Southern blot analysis revealed no differences between normal and affected animals.</p></sec><sec><title>Conclusions</title><p>Canine <italic>PAX6</italic> was cloned and characterized, and results provide sequence information for gaps in the current canine genome sequence. Canine <italic>PAX6</italic> nucleotide and amino acid sequences, as well as gene organization and map location, were highly homologous with that of the human gene. <italic>PAX6</italic> was evaluated in dogs with an inherited form of aniridia, and sequence analysis indicated no pathological mutations in the coding regions or splice sites of aniridia-affected dogs, and Southern blot analysis showed no large deletions.</p></sec></abstract><custom-meta-wrap><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Mutations in the paired-box 6 (<italic>PAX6</italic>) gene cause aniridia in man, a panocular disorder primarily characterized by complete or partial absence of iris tissue. Aniridia is often associated with other ocular abnormalities including corneal dystrophy, cataract, and glaucoma. The disease has a high penetrance, but variable expressivity, and, within pedigrees, phenotypes can vary in patients having the same mutation [<xref ref-type="bibr" rid="r1">1</xref>]. The incidence of aniridia is 1:65,000-1:100,000 in man, and approximately 2/3 of aniridia cases are inherited. In addition to aniridia, <italic>PAX6</italic> mutations (OMIM <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?omim=607108">607108</ext-link>) can also cause Peter's anomaly, cataract, corneal dystrophy, keratitis, coloboma, ectopic pupillae, foveal hypoplasia, and optic nerve hypoplasia. Over 300 <italic>PAX6</italic> mutations have been described in man, and can be viewed at the Human <italic>PAX6</italic><ext-link ext-link-type="uri" xlink:href="http://pax6.hgu.mrc.ac.uk/">Allelic Variant Database</ext-link>. <italic>PAX6</italic> mutations are dominant to semidominant and homozygous lethal. Homozygous or compound heterozygous patients have anophthalmia and multiple, severe CNS malformations [<xref ref-type="bibr" rid="r2">2</xref>,<xref ref-type="bibr" rid="r3">3</xref>].</p><p><italic>PAX6</italic> is expressed during embryogenesis in the developing CNS, eye, nose, pituitary, and pancreas [<xref ref-type="bibr" rid="r4">4</xref>-<xref ref-type="bibr" rid="r8">8</xref>]. It functions as a master control gene in ocular development across species, both vertebrate and invertebrate, and is able to induce ectopic eye development in <italic>Drosophila melanogaster</italic> [<xref ref-type="bibr" rid="r9">9</xref>] and <italic>Xenopus laevis</italic> [<xref ref-type="bibr" rid="r10">10</xref>]. Mutations in the <italic>Drosophila PAX6</italic> homolog <italic>eyeless</italic> cause partial to complete loss of the compound eye, and surrounding sensory bristles [<xref ref-type="bibr" rid="r11">11</xref>]. <italic>Pax6</italic> mutations in mouse are dominant, and result in the <italic>small eye</italic> (<italic>sey</italic>) phenotype characterized by microphthalmia and small body size [<xref ref-type="bibr" rid="r12">12</xref>]. Experimentally induced mutations in mouse <italic>Pax6</italic> exhibit a range of phenotypes, including partial to complete aniridia, iris abnormalities, cataract, and corneal adhesions [<xref ref-type="bibr" rid="r13">13</xref>]. Homozygous <italic>Pax6</italic> mutations are lethal in the mouse, and, as in man, result in small embryos with anopthalmia and severe CNS malformations [<xref ref-type="bibr" rid="r3">3</xref>,<xref ref-type="bibr" rid="r12">12</xref>].</p><p><italic>PAX6</italic> is a highly conserved member of the PAX family of DNA-binding transcription factors. It contains a paired domain (PD), a linker region, a homeodomain (HD), and a proline-serine-threonine rich (PST) region which functions as a transcription activator [<xref ref-type="bibr" rid="r3">3</xref>]. Both the paired and homeo domains of the PAX6 protein recognize and bind to DNA target sequences. The paired domain is further divided into an NH<sub>2</sub>-terminal subdomain (NTS) and a COOH-terminal subdomain (CTS). An alternatively spliced form of PAX6 inserts an additional 14 amino acids, encoded by exon 5a, into the NTS of the paired domain, thereby altering its binding ability [<xref ref-type="bibr" rid="r14">14</xref>,<xref ref-type="bibr" rid="r15">15</xref>]. In the shorter PAX6, the NTS binds to DNA targets while in the longer PAX6(5a) the CTS preferentially binds. Thus, the NTS and the CTS apparently negatively regulate each other allowing the alternatively spliced exon 5a to act as a molecular switch which can determine DNA-binding targets [<xref ref-type="bibr" rid="r14">14</xref>,<xref ref-type="bibr" rid="r16">16</xref>].</p><p>In an effort to identify the causal gene, and mutation responsible for canine aniridia, a family of Spanish Catalan sheepdogs with an inherited form of aniridia was analyzed. Affected dogs presented with partial to nearly complete absence of the iris with or without keratitis, cataract, and glaucoma. Because limited pedigree information and samples precluded a genome wide scan, a candidate gene approach was used. <italic>PAX6</italic> was selected for evaluation because it is the primary aniridia gene in man. The canine <italic>PAX6</italic> has not been cloned, and the current draft of the <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/cgi-bin/hgGateway">canine genomic sequence</ext-link> [<xref ref-type="bibr" rid="r17">17</xref>] does not contain an annotated <italic>PAX6</italic>. Moreover, the canine draft genomic sequence does not contain the entire sequence for this gene. As a result, <italic>PAX6</italic> was cloned from a canine retinal cDNA library, characterized, and evaluated for mutations that could be causally associated with the disease.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Animals and DNA</title><p>Catalan sheepdogs (Gos d'Atura) with an inherited form of aniridia were ascertained by Dr. Manuel Villagrasa at the Veterinary Ophthalmology Center in Madrid, Spain [<xref ref-type="bibr" rid="r18">18</xref>]. The dogs were privately owned pets or working sheepedogs, and were not part of a research colony. Dogs were examined using direct and indirect ophthalmoscopy and slit lamp biomicroscopy. Clinical signs included partial to nearly complete absence of the iris with ciliary processes visible at the circumferential border (<xref ref-type="fig" rid="f1">Figure 1</xref>). Some canine patients also exhibited persistent remnants from the pupillary membrane, corneal edema, keratitis, cataract, and glaucoma. A total of 10 dogs were examined, including 7 which were part of one pedigree (GD2, GD3, GD5, GD6, GD8, GD9, and GD10; <xref ref-type="fig" rid="f2">Figure 2</xref>), and 3 which were unrelated (GD12, GD13, and GD14). Six dogs were affected with aniridia (GD5, GD6, GD9, GD10, GD12, and GD14), and 4 were normal (GD2, GD3, GD8, and GD13). Although the pedigree information available was very limited, the disease appeared to segregate as an autosomal recessive trait in that aniridia-affected dogs were produced from phenotypically normal parents (<xref ref-type="fig" rid="f2">Figure 2</xref>) [<xref ref-type="bibr" rid="r18">18</xref>]. Whole blood was collected in EDTA-anticoagulant tubes, and total genomic DNA (gDNA) was extracted from blood lymphocytes using standard phenol:chloroform extraction protocols with ethanol precipitation [<xref ref-type="bibr" rid="r19">19</xref>].</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>The canine aniridia phenotype. Note the absence of iris, visible ciliary processes located near the lens equator (white arrowheads) and pupillary membrane remnants (black arrows).</p></caption><graphic xlink:href="mv-v13-431-f1"/></fig><fig id="f2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>Spanish Catalan sheepdog pedigree showing aniridia-affected dogs. Note that the parents of affected dogs in 3 of the matings were clinically normal.</p></caption><graphic xlink:href="mv-v13-431-f2"/></fig></sec><sec><title>Cloning and characterization of canine <italic>PAX6</italic></title><p>Oligonucleotide primers were designed based on human (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=XM_012065">XM_012065</ext-link>) and mouse (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=X63963">X63963</ext-link>) <italic>PAX6</italic> consensus sequences using Amplify&#x000a9; software (Bill Engels, University of Wisconsin, Madison, WI). <italic>PAX6</italic> was amplified from a canine retinal cDNA library made with the pBK-CMV phagemid vector (Stratagene, LaJolla, CA), using primers listed in <xref ref-type="table" rid="t1">Table 1</xref>. Vector primers PBKIII and PBKVI from the cDNA library were used to extend the resulting <italic>PAX6</italic> sequence in the 5' and 3' directions, respectively. Additional sequence information was obtained from The Institute for Genomic Research (TIGR) 1.5X (poodle) canine genomic sequence [<xref ref-type="bibr" rid="r20">20</xref>]. Additional primers were designed to cross introns in gDNA in order to obtain the intron/exon boundary sequences which were then used to design primers for exon scanning. Intron/exon boundaries were analyzed, and intronic sizes were determined for 9 of the 13 introns. For the larger introns (2, 4, 7, and 11), which could not be amplified directly, genomic sequence at the intron/exon boundaries was obtained from TIGR (poodle) canine genomic sequence [<xref ref-type="bibr" rid="r20">20</xref>], and used to design primers for exon scanning.</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Primer sequences used to clone <italic>PAX6</italic> from a canine retinal cDNA library.</title></caption><table frame="hsides" rules="groups"><col width="73" span="1"/><col width="58" span="1"/><col width="218" span="1"/><col width="33" span="1"/><col width="63" span="1"/><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Primer<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Location<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Sequence<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Tm (&#x000b0;C)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Product size (bp)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-1F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">exons 4-5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GCAGAACAGTCACAGCGGAGTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">464<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-3R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">exon 7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCGTCTGCGCCCATCTGTTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">61.4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-4F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">exon 7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GTCATCAATAAACAGAGTTCTTCGC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">54.3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">485<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-5R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">exon 10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GTGTTGCTGGCCTGTCTTCTCTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60.1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-6F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">exon 9<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GATCTACCTGAAGCAAGAATACAGG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">54.9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">380<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-7R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">exon 12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GGTGTAGGTATCATAACTCCG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">51.9<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td colspan="5" valign="top" align="left" scope="col" rowspan="1">Primers used to clone 5' end of PAX6<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PBKIII F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">vector<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GGTCGACACTAGTGGATCCAAAG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">550<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-3R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">exon 7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCGTCTGCGCCCATCTGTTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">61.4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td colspan="5" valign="top" align="left" scope="col" rowspan="1">Primers used to clone 3' end of PAX6<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-6F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">exon 9<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GATCTACCTGAAGCAAGAATACAGG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">54.9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">600<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PBKVI R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">vector<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GCTCTCATGAAGATCTCGCCG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57.7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-27F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">exon 12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">AACAGTCAGCCAATGGGCAC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">53.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">200<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PBKVI R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">vector<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GCTCTCATGAAGATCTCGCCG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57.7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td colspan="5" valign="top" align="left" scope="col" rowspan="1">Primers used to amplify alternatively transcribed EXON 5a<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-14F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">exon 5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTCGGTGGTGTCTTTGTCAAC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">54.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">250<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-15R</td><td valign="top" align="left" rowspan="1" colspan="1">exon 6</td><td valign="top" align="left" rowspan="1" colspan="1">CTACTCTCGGTTTACTACCACC</td><td valign="top" align="center" rowspan="1" colspan="1">54.7</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><p>PCRs for the cloning of <italic>PAX6</italic> were run in a 25 &#x003bc;l reaction volume with the following conditions: 2 min at 94 &#x000b0;C followed by 30 cycles of 60 s at 94 &#x000b0;C, 60 s at 58 &#x000b0;C, 60 s at 72 &#x000b0;C, and a final extension of 7 min at 72 &#x000b0;C. PCRs were run on Amplitron II&#x000ae; Thermolyne thermocyclers (Barnstead Thermolyne Co., Dubuque, IA), and amplified products were electrophoresed on 2% agarose gels (Invitrogen, Carlsbad, CA) with 1X TAE buffer (0.04 M Tris-acetate buffer, pH 8, 100 mM EDTA) at 60V. Gels were stained with ethidium bromide, visualized using an ultraviolet transilluminator (Spectronics Corporation, Westbury, NY), and digitally photographed. PCR products were purified using the Concert<sup>TM</sup> PCR purification kit (Gibco, BRL, Gaithersburg, MD), or gel bands were excised and purified using the Qiaex II&#x000ae; Gel Extraction kit (Qiagen Inc., Valencia, CA). Purified PCR products were then sequenced on the Applied Biosystems Automated 3730 DNA Analyzer using Big Dye Terminator chemistry and Ampli Taq-FS DNA Polymerase. Sequence assembly and analysis were performed using Sequencher<sup>TM</sup> software (Gene Codes Corporation, Ann Arbor, MI).</p></sec><sec><title>Exon scanning</title><p><italic>PAX6</italic> exons, along with their intron/exon junctions, were scanned using PCR amplification of gDNA from 4 aniridia-affected dogs (GD5, GD6, GD9, and GD10), and 3 non-affected dogs (GD2, GD3, and GD8) from the same pedigree. In addition, one non-affected unrelated Beagle (B15) was scanned as a control. Primers were designed in introns near the intron/exon boundaries (<xref ref-type="table" rid="t2">Table 2</xref>) using Amplify software. Primers in nearby exons were used in the amplification of exons 5a, 6, 9, 10, and 11. PCR and electrophoresis conditions were the same as those described earlier. Gel bands corresponding to exon sizes were excised and gel purified using the QIAquick&#x000ae; Gel Extraction kit (Qiagen Inc.). Gel-purified PCR products were sequenced and analyzed as previously described.</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title><italic>PAX6</italic> primer sequences used for exon scanning.</title></caption><table frame="hsides" rules="groups"><col width="36" span="1"/><col width="116" span="1"/><col width="218" span="1"/><col width="42" span="1"/><col width="48" span="1"/><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">Exon<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Primer (location)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Primer sequence<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Tm (&#x000b0;C)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Product size (bp)<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-40F (5'UTR)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TCAGGCGCAGGAGGAAGTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">59.9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">194<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-41R (intron 1)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TCAGCGGCTGGAGAGTGAG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">59.3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-42F (intron 1)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTCACTCTCCAGCCGCTGAC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">400<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-43R (intron 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTCTCCCGGCGTGGCAGTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">63.6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-44F (intron 2)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GAGAGTCCATGGGCCTGTGC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">200<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-45R (intron 3)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTTCTCCCATGTGAACAATGAAG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">53.9<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-84F (intron 3)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GCGACTGAGTGGATCCCTTC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">58.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">302<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-83R (intron 4)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCCTCCAGCCGGACTGC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">61<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-86F (intron 4)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCGCATGGACGTGTGGTCC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">61.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">558<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-79R (intron 5)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GGAGTTATCTTATGTGACTGAC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">51.4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">5A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-50F (intron 5)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTCTCTACAGTAAGTTCTCATAC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">49.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">210<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-39R (exon 6)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCAGTCTCGTAATACCTGCC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">53.7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PAX6-34F (exon 5A)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GTCCAAGTGCTGGACAATC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">51<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">917<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PAX6-29R (intron 6)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">AACAAGCTCCCAGCCATCCT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">53.7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-51F (intron 6)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GTTGTTCTTTAAGAGAGTGGGTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">53.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">310<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-52R (intron 7)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCAGTGGCTGCCTATATGGAG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57.3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-53F (intron 7)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GCCTCTTTGGGAGGCTCCAAG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">300<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-54R (intron 8)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTGGCTAAATATAGCTCTTTGTAC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">51.2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PAX6-30F (intron 8)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GCCACATCTTCAGTACAAAG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">49.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">800<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-21R (exon 10)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GCCTGTCTTCTCTGGTTCC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">53.1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">10<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PAX6-6F (exon 9)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GATCTACCTGAAGCAAGAATACAGG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">54.9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">590<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-23R (exon 11)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GTGTTTGTGAGGGCTGTGTC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">53.7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">11<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-22F (exon 10)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCCAGTCACATCCCCATCAG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">350<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-55R (intron 11)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCCACTCCTCGCTTCTCCG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60.1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">12<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-61F (intron 11)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CGATCATCAGGCTATCATAC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">49.9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">415<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-62R (intron 12)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCAGGAGGTTTCTCTTAAGG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">52.2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">13<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PX6-63F (intron 12)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CATAGTCCATGCTTGTCTCTC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">52.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">318<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">PX6-88R (3'UTR)</td><td valign="top" align="left" rowspan="1" colspan="1">CACAGGACACAACTGCAGAAC</td><td valign="top" align="center" rowspan="1" colspan="1">57.4</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></sec><sec><title>Radiation Hybrid Mapping</title><p>Canine <italic>PAX6</italic> was positioned on a radiation hybrid map using a canine/hamster radiation hybrid (RH3000) panel consisting of 92 cell lines made by fusing 3000 rad-irradiated canine fibroblast cells with TK-HTK3 hamster cells (Research Genetics, Inc., Huntsville, AL). Canine <italic>PAX6</italic> was linked to CFA18 in relation to 7 gene markers (<italic>WT1</italic>, <italic>CD44</italic>, <italic>COLF1</italic>, <italic>COLF2</italic>, <italic>DLA79</italic>, <italic>ROM1</italic>, and <italic>TPCR63</italic>) and 7 microsatellite markers (Wilms-TF, REN47J11, REN248C19, C18.156, C18.460, AHT130, and FH2356). All of these markers were previously mapped and positioned on CFA18 [<xref ref-type="bibr" rid="r21">21</xref>,<xref ref-type="bibr" rid="r22">22</xref>]. Primers for RH mapping are listed in <xref ref-type="table" rid="t3">Table 3</xref>. <italic>PAX6</italic> primers 30F and 21R, which amplify intron 8, were used to amplify <italic>PAX6</italic> in the RH3000 panel.</p><table-wrap id="t3" position="float"><label>Table 3</label><caption><title>Primers used for radiation hybrid mapping.</title></caption><table frame="hsides" rules="groups"><col width="252" span="1"/><col width="212" span="1"/><col width="38" span="1"/><col width="67" span="1"/><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PRIMER<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">PRIMER SEQUENCE<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Tm (&#x000b0;C)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">PRODUCT SIZE (bp)<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-30F (intron 8)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GCCACATCTTCAGTACAAAG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">49.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">300<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-31R (intron S)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TAGTTCAGGCATTGACTGATG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">50.3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1 WT1 (Wilms tumor 1)-F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GGTGCCTGGAAACGTCCG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">59.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">155<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WT1 (Wilms rumor 1)-R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ACCGGGAGAACTTTCGCTGAC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">59 5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1 CD44 (Cell differentiation antigen 44 variant)-F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGGAAGAGAAGGTGGACATCTTCC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">58.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">106<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">CD44 (Cell differentiation antigen 44 variant)-R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GGTCACCGGGATGAGGGTC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60.1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">COLF1 (Canine olfactory receptor gene 1) -F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GTCTCGGGGCATCTGTGTAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">357<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">COLF1 (Canine olfactory receptor gene 1) -R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GATGGCCACAGAAGTCAGGT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57.4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">COLF2 (Canine olfactorv receptor sene 2)-F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">AGAGTGTGCTCCCTGCTGAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">357<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">COLF2 (Canine olfactory receptor sene 2)-R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGCAACAGCAGTTAAGTGGG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55.4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">DLA79 MHC class IB) -F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TCTATTCTGGCATTGGGGAC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">270<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">DLA79 (MHC class IB) -R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGAGTAGCTCCCTCCTTTTCTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">58.1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">ROM1 -F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTCTTTGATCCTCGTCAGCC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">230<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">ROM1 -R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGAGGGTCAGTAGGTCCCTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">59.5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">TPCR63 (Putative olfactory receptor)-F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">AGGATACGTTCCTCAGAGGGCC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">61.9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">129<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">TPCR63 (Putative olfactory receptor)-R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ATCTAATGAGTGGTTGGTCCCTGGT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60.6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Wilms-TF (tetra repeat)-F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCCAATCTCCAGAGATTTTCC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">52.3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">300<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Wilms-TF (tetra repeat)-R<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCAGTCTCAGCTGTGTCCAA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">53.7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">REN47J11-F (CA)ll<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TCTCCTCGCGTGTTTCTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">50.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">163<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">REN47J11-R (CA)ll<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GGGGACACTCAGAAGGACG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55.3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">REX24SC19-F(CA)10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGACTGTGGCAAGCAAGAAC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">51.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">319<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">REX24SC19-R (CA)10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GGCAAAGAAAGATGGACTGG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">51.7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">C1S.156-F(AC)15<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ACAACCAACACACACAAAAACC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">54.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">136<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">C18.156-R(AC)15<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGTTATCCCAGTGGCATTAGG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">54.5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">C18.460-F (TG)17<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTTCCCATTATAGCCCTGTCC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">54.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">147<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">C18.460-R (TG)17<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GGTGTCAGG AAAATGAGACCA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">548<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">AHT130-F (GT)19<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCTCTCCTGGTAAGTGCTGC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">113<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">AHT130-R (GT)19<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGGAACACTGGTCCCCAG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57.0<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">FH2356-F (tetra repeat)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTTGCATTCCCGCTCTCACT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">235<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">FH2356-R (tetra repeat)</td><td valign="top" align="left" rowspan="1" colspan="1">TCCTGAAATAGCTCCAGCGC</td><td valign="top" align="center" rowspan="1" colspan="1">57.4</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><p>PCR reactions were run on the 92 cell lines of the RH3000 panel, in duplicate or triplicate, at 25 &#x003bc;l volume. PCR conditions were as follows: 2 min at 94 &#x000b0;C, followed by 30 cycles of 30 s at 94 &#x000b0;C, 30 s at 56 &#x000b0;C, 30 s at 72 &#x000b0;C, and a final extension of 5 min at 72 &#x000b0;C. PCRs were optimized by adjusting the annealing temperature as needed. PCR products were electrophoresed and analyzed as described earlier. Gel images were recorded for each gel and scored for presence or absence of the band of interest in each of the 92 cell lines. Radiation hybrid data was analyzed using Multimap&#x000ae; software [<xref ref-type="bibr" rid="r23">23</xref>].</p></sec><sec><title>Association Testing</title><p>Ten dogs, 6 affected and 4 non-affected, were used to test for association of aniridia with the <italic>PAX6</italic> locus. Seven of the ten animals were part of one small pedigree and 3 were unrelated (<xref ref-type="fig" rid="f3">Figure 3</xref>). Autosomal recessive inheritance was assumed based on a previous report [<xref ref-type="bibr" rid="r18">18</xref>], and limited pedigree information, but phenotypic variability, prevented the exclusion of dominant inheritance with incomplete penetrance. In addition, a founder effect mutation was hypothesized based on the small breed size. This mutation appears to have occurred recently in that the previous clinical [<xref ref-type="bibr" rid="r18">18</xref>] report is the first and only description of aniridia in the breed, and, as this is a working dog breed, the visual impairment caused by aniridia would be readily recognized in these dogs once it occurred.</p><fig id="f3" fig-type="figure" position="float"><label>Figure 3</label><caption><p>Test for association of aniridia phenotypes with CFA18 markers. Four microsatellites and 2 single nucleotide polymorphisms were analyzed in 10 dogs (6 affected, and 4 non-affected). Two of the 6 affected dogs were heterozygous; one of these was hetrozygous for the <italic>PAX6</italic> exon 7 SNP.</p></caption><graphic xlink:href="mv-v13-431-f3"/></fig><p>Four microsatellite markers (C18.156, COS18, Wilms-TF, and REN47J11) which were previously mapped to CFA18 using an RH5000 panel [<xref ref-type="bibr" rid="r21">21</xref>,<xref ref-type="bibr" rid="r22">22</xref>] were used for association testing along with 2 SNPs identified within canine <italic>PAX6</italic>: one in exon 7 and one in intron 8. In exon 7 there is a T&#x0003e;C change (ACT&#x0003e;ACC) at nucleotide 501 of the 1,311 bp coding sequence (PAX6(5a)) that does not alter the translated amino acid (threonine). In intron 8 (which is 484 bp), there is a G&#x0003e;A change at intronic nucleotide position 351.</p><p>Primers used for association testing, along with PCR product sizes, genomic locations, and inter-marker distances are listed in <xref ref-type="table" rid="t4">Table 4</xref>. The previous RH5000 map placement of the 4 microsatellite markers gives 22.0 cRays between C18.156 and COS18, 57.5 cRays between COS18 and Wilms-TF, and 64.7 cRays between Wilms-TF and REN47J11 [<xref ref-type="bibr" rid="r22">22</xref>]. According to the current genomic sequence, <italic>PAX6</italic> lies between Wilms-TF and REN47J11 (<xref ref-type="table" rid="t4">Table 4</xref>). PCRs were run as previously described, and products for microsatellite markers were electrophoresed on 6% polyacrylamide gels, and microsatellite sizes were scored for each animal. PCR products for the exon 7 SNP were electrophoresed on 2% agarose gels (Invitrogen), gel purified, sequenced, and analyzed as previously described. Intron 8 PCR products were digested with <italic>Bst</italic>NI (New England Biolabs, Ipswich, MA) and electrophoresed on 6% polyacrylamide gels. Dogs homozygous (G/G) for the intron 8 SNP had 230 bp and 220 bp bands, while heterozygous dogs (G/A) had 230 bp, 220 bp, and 450 bp bands after enzyme digestion. Homozygous (A/A) dogs would have a 450 bp band, but there were none in this pedigree.</p><table-wrap id="t4" position="float"><label>Table 4</label><caption><title>Primer sequences used for association testing and genomic location of amplicons.</title></caption><table frame="hsides" rules="groups"><col width="67" span="1"/><col width="197" span="1"/><col width="31" span="1"/><col width="48" span="1"/><col width="146" span="1"/><col width="52" span="1"/><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Primer name<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Primer sequence<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Tm (&#x000b0;C)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Product size (bp)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Canine genomic&#x02028;sequence location<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Distance between markers<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">C18.156-F (AC)15<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ACAACCAACACACACAAAAACC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">54.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">136<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Chr18:25401870+25402003<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">C18.156-R (AC)15<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGTTATCCCAGTGGCATTAGG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">54.5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.2 Mb<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">COS-18-F (TC)19<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CGTGGTGCCGGCCCTTTGAT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">63.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">360<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Chr18:27577535-30076377*<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">COS-18-R (TC)19<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TTTAGCGCCTGCCTTTGGAC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">58.4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8.1 Mb<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Wilms-TF-F (tetra repeat)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCCAATCTCCAGAGATTTTCC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">52.3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">300<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Chr18:38163822+38164112<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Wilms-TF-R (tetra repeat)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCAGTCTCAGCTGTGTCCAA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">53.7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">510 Kb<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-51F (exon 7 SNP)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GTTGTTCTTTAAGAGAGTGGGTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">53.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">310<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Chr18:38675041-38687464**<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-52R (exon 7 SNP)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCAGTGGCTGCCTATATGGAG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57.3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.8 Kb<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-30F (intron 8 SNP)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GCCACATCTTCAGTACAAAG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">49.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">824<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Chr18:38687699+38688522<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PAX6-21R (intron 8 SNP)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GCCTGTCTTCTCTGGTTCC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">53.1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.6 Mb<hr/></td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">REN47J11-F (CA)11<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TCTCCTCGCGTGTTTCTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">50.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">163<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Chr18:45329434-45329603<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">REN47J11-R (CA)11</td><td valign="top" align="left" rowspan="1" colspan="1">GGGGACACTCAGAAGGACG</td><td valign="top" align="center" rowspan="1" colspan="1">55.3</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p>The exact location of <italic>COS18</italic>* and <italic>PAX6</italic> exon 7** could not be determined in the current canine genome draft sequence. The site given for <italic>COS18</italic> represents the region between its flanking markers BAC_375-H17 and BAC_373-K16 [<xref ref-type="bibr" rid="r24">24</xref>,<xref ref-type="bibr" rid="r25">25</xref>]. The site given for exon 7 represents the last sequence before a gap in the genome which occurs in intron 4, and the calculated location of the beginning of exon 8, which is also located within the gap.</p></table-wrap-foot></table-wrap></sec><sec><title>Southern blot</title><p>Southern (DNA) analysis was performed using 10 &#x003bc;g of gDNA from two non-affected dogs (GD2 and GD8), two affected progeny (GD6 and GD10), and one control dog (beagle). Genomic DNA was digested with restriction enzyme <italic>Eco</italic>R1 (New England Biolabs, Ipswich, MA), electrophoresed on a 0.8% agarose gel, and transferred to a nylon hybridization transfer membrane (GeneScreen Plus&#x000ae; Perkin Elmer, Boston, MA). The nylon membrane was prehybridized and hybridized with ExpressHyb<sup>TM</sup> (Clontech, Palo Alto, CA). Probes were labeled with a P<sup>32</sup>dCTP (3,000 Ci/mmol, 10 mCi/ml) using the RadPrime DNA Labeling System (Life Technologies<sup>TM</sup>, Inc Palo Alto, CA).</p><p>Two probes were designed from the canine <italic>PAX6</italic>. A 580 bp fragment, including all of exon 1, intron 1, exon 2, and part of intron 2, was used as a 5'UTR probe. This probe was amplified using primers <italic>PAX6</italic>-40F and 43R (<xref ref-type="table" rid="t2">Table 2</xref>). A 373 bp fragment in the PST domain, including part of intron 11, all of exon 12 and part of intron 12, was used as a 3' end probe. This probe was amplified using <italic>PAX6</italic>-61F and 62R (<xref ref-type="table" rid="t2">Table 2</xref>). Each probe was amplified in gDNA, gel purified using the QIAquick&#x000ae; Gel Extraction kit (QiagenIAGEN Inc.), and verified by sequencing.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Characterization of canine <italic>PAX6</italic></title><p>A 1,072 bp fragment of canine <italic>PAX6</italic> cDNA, representing the 3' end of exon 4 through the 5' end of exon 12, was amplified from a canine retinal cDNA library using primers designed from human/mouse <italic>PAX6</italic> consensus sequence (<xref ref-type="table" rid="t1">Table 1</xref>). cDNA library vector primers, PBKIII and PBKVI, were used to extend the sequence to 1,472 bp which included the 3' end of exon 2 through the 5' end of exon 13. This fragment contained the complete <italic>PAX6</italic> coding sequence for isoform a, which does not contain the alternatively transcribed exon 5a. This 1,269 bp coding sequence began at the ATG start codon in exon 4, and ended at the TAA stop codon in exon 13. A poly-A sequence of at least 20 residues followed the stop codon, and it was unclear where non-coding exon 13 ended. Similarly, in man the ATG start codon occurs in exon 4, and the TAA stop codon in exon 13 is followed by a poly-A sequence of 21 residues. Exon 13 in man is estimated to be 1,110 bp (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_001604">NM_001604</ext-link>). Unlike the human and canine genes, mouse <italic>Pax6</italic> contains 12 exons instead of 13, and mouse exons 2-12 correspond with human and canine exons 3-13 (<xref ref-type="fig" rid="f4">Figure 4</xref>). As a result, the mouse ATG start codon is in exon 3 (instead of exon 4), and the TAA stop codon is in exon 12 (instead of exon 13), and it is not followed by a poly-A sequence (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_013627">NM_013627</ext-link>).</p><fig id="f4" fig-type="figure" position="float"><label>Figure 4</label><caption><p>Comparison of canine, human and mouse <italic>PAX6</italic> organization. Open boxes represent non-coding exons, and closed boxes represent coding exons. Exon sizes are given above exon boxes. Lines represent introns with sizes written above.</p></caption><graphic xlink:href="mv-v13-431-f4"/></fig><p>A 42 bp alternatively transcribed exon 5a was amplified from the canine retinal cDNA library, and was located between exons 5 and 6, as in man. This alternatively transcribed exon is located between exons 4 and 5 in the mouse. The coding sequence for canine <italic>PAX6</italic> isoform b, which includes this alternatively transcribed exon, was 1,311 bp, and was the same length as the human and mouse <italic>PAX6</italic>(5a) coding sequences.</p><p>Sequences for exon 1 and the 5' end of exon 2 could not be amplified from the cDNA library, and were obtained from the TIGR 1.5X (poodle) canine genomic sequence [<xref ref-type="bibr" rid="r20">20</xref>]. Within the 5' UTR, the predicted sizes for canine exons 1 and 2, and introns 1 and 2, were similar in size to the corresponding human exons and introns (<xref ref-type="table" rid="t5">Table 5</xref>). Exon 1 was predicted to be 103 bp based on the TIGR canine genomic sequence, and sequences amplified from genomic DNA in canine patients. In man, <italic>PAX6</italic> exon 1 is 119 bp (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_001604">NM_001604</ext-link>) or 196 bp (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_000280">NM_000280</ext-link>). <italic>PAX6</italic> exon 2 is 188 bp in man (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_001604">NM_001604</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_000280">NM_000280</ext-link>), and predicted to be 224 bp in the dog. The additional 36 bp in canine exon 2 included a 23 bp poly-A sequence near the center of the exon followed by highly repetitive sequence. In the mouse, the comparable exon 1 is 386 bp (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_013627">NM_013627</ext-link>), while exon 2 is 80 bp and corresponds with human and canine exon 3 (77 bp; <xref ref-type="fig" rid="f4">Figure 4</xref> and <xref ref-type="table" rid="t5">Table 5</xref>).</p><table-wrap id="t5" position="float"><label>Table 5</label><caption><title>Comparison of human, canine and mouse <italic>PAX6</italic> exon and intron sizes.</title></caption><table frame="hsides" rules="groups"><col width="95" span="1"/><col width="63" span="1"/><col width="58" span="1"/><col width="112" span="1"/><col width="67" span="1"/><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold><italic>PAX6</italic> EXONS &#x00026; INTRONS</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>HUMAN* SIZES (bp)</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>CANINE SIZES (bp)</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>MOUSE EXONS/ INTRONS</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>MOUSE** SIZES (bp)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">EXON 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">119<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">103<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">INTRON 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">197<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">99<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">EXON2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">188<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">224<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">EXON 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">386<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">INTRON 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">3902<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02265;1704<sup>&#x02020;</sup><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">INTRON 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2971<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">EXON3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">77<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">77<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">EXON 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">80<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">INTRON 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">386<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">366<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">INTRON 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">357<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">EXON 4 (ATG)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">61<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">61<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">EXON 3 (ATG)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">61<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">INTRON 4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">3567<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02265;3492<sup>&#x00394;</sup><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">INTRON 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">3520<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">EXON 5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">131<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">131<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">EXON 4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">131<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">INTRON 5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">791<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">792<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">INTRON 4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">792<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">EXON 5A<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">42<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">42<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">EXON 4a<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">42<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">INTRON 5A<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">94<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">94<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">INTRON 4a<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">94<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">EXON 6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">216<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">216<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">EXON 5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">216<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">INTRON 6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">704<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">737<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">INTRON 5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">675<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">EXON 7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">166<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">166<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">EXON 6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">166<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">INTRON 7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">5902<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02265;2417<sup>&#x02020;</sup><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">INTRON 6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">5621<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">EXON 8<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">159<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">159<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">EXON 7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">159<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">INTRON 8<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">515<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">484<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">INTRON 7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">470<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">EXON 9<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">83<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">83<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">EXON 8<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">83<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">INTRON 9<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">229<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">234<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">INTRON 8<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">193<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">EXON 10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">151<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">151<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">EXON 9<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">151<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">INTRON 10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">98<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">99<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">INTRON 9<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">116<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">EXON 11<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">116<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">116<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">EXON 10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">116<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">INTRON 11<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2577<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02265;2816<sup>&#x00394;</sup><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">INTRON 10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2453<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">EXON 12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">151<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">151<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">EXON 11<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">151<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">INTRON 12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">690<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">716<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">INTRON 11<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">813<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">EXON 13 (TAA)</td><td valign="top" align="left" rowspan="1" colspan="1">1110</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003e;99</td><td valign="top" align="left" rowspan="1" colspan="1">EXON 12 (TAA)</td><td valign="top" align="left" rowspan="1" colspan="1">799</td></tr></tbody></table><table-wrap-foot><p>The asterisk indicates that human sizes were determined using reference sequence <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_001604">NM_001604</ext-link> and the UCSC human genome sequence. The double asterisk indicates that mouse sizes were determined using reference sequence <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_013627">NM_013627</ext-link> and the UCSC mouse genome sequence. The "cross" indicates that canine intron 2 and 7 estimates are based on the TIGR 1.5X (poodle) sequence. &#x00394;Canine intron 4 and 11 estimates are based on UCSC 7.5X (boxer) sequence. The complete size of canine exon 13 is unknown. The ATG start codon is located in human and canine exon 4, and mouse exon 3. The TAA stop codon is located in human and canine exon 13, and mouse exon 12.</p></table-wrap-foot></table-wrap><p>The canine <italic>PAX6</italic> cDNA sequence (1,786 bp) representing exons 1-13, including exon 5a, and a 20 bp poly-A 3' end, was analyzed against the 2005 canine 7.6X genomic sequence (boxer) using the <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/cgi-bin/hgBlat?command=start">blat</ext-link> function. As of November, 2006, there was 99.9% identity spanning &#x0003e;21 kb in the genomic sequence (38,671,042-38,692,610) on chromosome 18. Matching sequences were identified for exons 3-4, and 9-13. However, <italic>PAX6</italic> exons 1-2 and 5-8 (including exon 5a) were missing from the current canine draft sequence. A 714 bp gap in the canine sequence, from 38,666,389-38,667,102, included predicted exons 1 and 2, while a second, larger 12,622 bp gap from 38,675,042-38,687,663, included exons 5-8. As a result, our cloned sequence provides the complete <italic>PAX6</italic> coding sequence (accession numbers EF141016, and EF141017) which was unavailable from the latest <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/cgi-bin/hgGateway">canine genomic sequence</ext-link>.</p><p>Primers designed to cross introns were used to determine intronic sizes for 9 of the 13 canine introns. The estimated sizes of the remaining 4 introns (2, 4, 7, and 11) were determined using genomic sequence information from TIGR 1.5X (poodle) [<xref ref-type="bibr" rid="r20">20</xref>] and the 7.6X (boxer) [<xref ref-type="bibr" rid="r17">17</xref>] public <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/cgi-bin/hgGateway">canine genome sequence</ext-link> (<xref ref-type="fig" rid="f4">Figure 4</xref>). Canine exons 3-12, and intron 5a are identical in size to the human counterparts, while exons 1, and 2, and introns 1-12 are similar in size (<xref ref-type="table" rid="t5">Table 5</xref>). Both canine and human isoform b (<italic>PAX6[5a]</italic>) nucleotide coding sequences were 1,311 bp and shared 97.3% identity, while the corresponding amino acid sequences shared 99.8% identity (<xref ref-type="fig" rid="f5">Figure 5</xref>). Interestingly, the canine and mouse coding sequences were only 93.2% identical, and had 89 nucleotide differences: 15-PD, 13-Linker, 11-HD, 50-PST. Eighty-four of the 89 nucleotide differences between dog and mouse occurred in the 3rd codon position and represented silent changes. Of the 5 nucleotide differences which occurred in the first codon position, only two resulted in an amino acid change: <italic>PAX6(5a)</italic> coding sequence nucleotide position 178 in exon 5a (PD) coded for glutamine (CAA) in the dog and man, but glutamic acid (GAA) in mouse; nucleotide position 1,213 in exon 12 (PST) coded for alanine (GCC) in the dog and threonine (ACC) in mouse and man.</p><fig id="f5" fig-type="figure" position="float"><label>Figure 5</label><caption><p>Comparison of the canine and human <italic>PAX6</italic> coding sequence (CDS), and amino acid sequence. Human (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_001604">NM_001604</ext-link>) CDS (first row); canine (EF141016) CDS (second row); corresponding amino acid sequence (436 aa; third row). The first underlined region is the paired domain (426 bp), followed by the linker region (234 bp). The second underlined region is the homeodomain (183 bp), followed by the PST domain (459 bp). The asterisks mark the 36 nucleotide differences between dog and man, two in the paired domain; three in the linker; five in the homeodomain; and 26 in the PST domain. Thirty-five of the 36 nucleotide differences occurred in the third position of the triplet codon, and did not alter the translated amino acid. Only one nucleotide difference occurred at the first position of a codon (base pair 1,213) resulting in an ACC (threonine) in man, and a GCC (alanine) in the dog. This change occurred in exon 12 which was part of the PST domain. As a result, the human and canine <italic>PAX6</italic> nucleotide coding sequences were 97.3% identical, and the corresponding amino acid sequences were 99.8% identical.</p></caption><graphic xlink:href="mv-v13-431-f5"/></fig></sec><sec><title>Exon scanning</title><p>The 14 exons of canine <italic>PAX6</italic> were scanned for mutations, including predicted exons 1 and 2, cloned exons 3-13, and the alternatively transcribed exon 5a. Splice sites at the intron/exon boundaries were also examined; at least 27 intronic nucleotides before each exon, and at least 30 intronic nucleotides after each exon were included in the analysis. <italic>PAX6</italic> exon scans were performed in 7 dogs that were part of one pedigree; this included 4 aniridia-affected dogs and 3 non-affected related dogs (<xref ref-type="fig" rid="f2">Figure 2</xref>). Non-coding exon 2 (224 bp) contained a 23 bp poly-A region followed by 6 AACC repeats. The first 133 bp of exon 2 was scanned in all 7 dogs, and the complete exon 2 sequence was scanned in 2 affected dogs (GD 5, 6) and 2 normal dogs (GD 3, 8). These 4 dogs had an extra AACC repeat in non-coding exon 2.</p><p><italic>PAX6</italic> exon scanning also revealed 2 single nucleotide polymorphisms (SNPs). The first was located in exon 7 at nucleotide position 501 (within the 1311 bp coding sequence), and involved a C&#x0003e;T change at the third position of the codon which did not alter the amino acid coded (ACC to ACT; threonine). The second SNP occurred in intron 8 (484 bp) at intronic nucleotide position 351, and was an A&#x0003e;G transition. Both of these SNPs were silent changes which did not alter the translated amino acids. No pathological mutations were identified in all 14 exons scanned or in their exon/intron junctions.</p></sec><sec><title>Radiation hybrid mapping</title><p>A canine/hamster radiation hybrid (RH3000) panel was used to link canine <italic>PAX6</italic> to CFA 18 in relation to 7 gene markers and 7 microsatellite markers (<xref ref-type="table" rid="t3">Table 3</xref>) which were mapped in previous studies [<xref ref-type="bibr" rid="r21">21</xref>,<xref ref-type="bibr" rid="r22">22</xref>]. Multimap&#x000ae; analysis could only place 8 of the 15 markers at unique map positions. <italic>PAX6</italic> and 6 other markers were placed on CFA18, but could not be localized to a unique position in relation to the other markers. However, two-point linkage analysis linked canine <italic>PAX6</italic> to Wilms-TF and WT1 on CFA18, with LOD scores of 8.0 and 7.1, respectively. Wilms-TF and WT1 are both located on CFA18 in a region with homology to HSA11p13 [<xref ref-type="bibr" rid="r22">22</xref>,<xref ref-type="bibr" rid="r24">24</xref>,<xref ref-type="bibr" rid="r25">25</xref>], which is where human <italic>PAX6</italic> is located. Similar map locations between the canine and human <italic>PAX6</italic> genes further supports their homology.</p></sec><sec><title>Association testing</title><p>Having excluded disease-associated changes in the coding sequence, we examined whether there was an association of <italic>PAX6</italic> with the disease locus. Ten Catalan sheepdogs (6 affected and 4 non-affected) were tested for association of <italic>PAX6</italic> with the aniridia phenotype. Seven of these dogs were related and part of the same pedigree, while 3 dogs were unrelated (<xref ref-type="fig" rid="f3">Figure 3</xref>). Because of the limited genetic studies to date, it was not definitive whether this disease was recessive or dominant. Based on a prior report [<xref ref-type="bibr" rid="r18">18</xref>], and the production of affected dogs from non-affected parents, recessive inheritance was assumed. Furthermore, based on the small breed size, we hypothesized also that all aniridia-affected dogs resulted from a founder-effect mutation. Thus, if the disease is autosomal recessive, all affected dogs would be homozygous for a common haplotype segment of CFA18. Alternatively, if the disease is autosomal dominant with incomplete penetrance, all affected dogs would have at least one common haplotype segment of CFA18.</p><p>Six polymorphic markers on CFA18 were analyzed that included 4 microsatellite markers (C18.156, COS18, Wilms-TF, and REN47J11), and 2 <italic>PAX6</italic> SNPs (exon 7 and intron 8). All 10 dogs examined shared at least one common haplotype for all 6 markers (<xref ref-type="fig" rid="f3">Figure 3</xref>; "111TG1"). Four of the 6 affected dogs (GD6, GD9, GD10, and GD14) were homozygous for this common haplotype, while 2 affected dogs (GD5 and GD12) were heterozygous. All affected dogs, regardless of homozygosity or heterozygosity for this haplotype, showed a broadly similar aniridia phenotype. Haplotypes for GD5 and GD12 were repeated to confirm their heterozygosity. All 4 unaffected dogs (GD2, GD3, GD8, and GD13) were heterozygous for the common haplotype. At 4 of the 6 individual marker loci (C18.156, COS18, WILMS-TF, and exon 7 SNP) both normal and affected dogs shared common genotypes. For 2 marker loci (intron 8 SNP and REN47J11) non-affected dogs had both homozygous and heterozygous genotypes while all affected dogs were homozygous. Furthermore, at each marker locus there were both affected and non-affected animals with identical genotypes. Such degree of haplotype sharing is not unexpected given the small breed size and degree of inbreeding.</p><p>Assuming recessive inheritance, our observations suggested no association of the <italic>PAX6</italic> locus with the aniridia phenotype. However, if aniridia segregates as a dominant disease in these dogs, our observations would suggest an association in that all affected dogs shared at least one common haplotype ("111TG1"). Incomplete penetrance could explain the presence of this commom haplotype in "non-affected" dogs (GD2, GD3, GD8, and GD13) that did not manifest the aniridia phenotype.</p></sec><sec><title>Southern blot analysis</title><p>A Southern blot analysis was performed using probes designed from both the 5' UTR (exon 1, intron 1, exon 2, and the 5' end of intron 2) and the 3' PST domain (3' end of intron 11, all of exon 12, and the 5' end of intron 12) of <italic>PAX6</italic>. Identical bands were found in affected and non-affected dogs from the aniridia pedigree, and a normal beagle control using both probes. The 5' UTR probe hybridized at about 8,500 bp, while the 3' PST probe hybridized at about 7,400 bp (data not shown). The absence of any distinction between the <italic>PAX6</italic> bands of affected and non-affected animals using both a 5' and a 3' end probe suggested that there were no large deletions present in the <italic>PAX6</italic> gene.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Human aniridia (OMIM <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?omim=106210">106210</ext-link>) patients show varying degrees of iris loss including complete to partial absence of the iris, iris coloboma, and thinning of the iris. They may also exhibit other related ocular abnormalities including cataract, keratitis, or glaucoma. In this study, the clinical manifestation of aniridia in a canine model strongly resembled that seen in human patients. Canine subjects showed total to nearly complete absence of the iris with ciliary processes visible at the circumferential border; in some cases, cataracts, corneal edema, and glaucoma also were present. The anatomical similarities between the dog and human eye, along with the clinical similarities in canine and human aniridia phenotypes, make the dog an important model for this disease.</p><p>Because the vast majority of aniridia cases in man are caused by mutations in the <italic>PAX6</italic> gene [<xref ref-type="bibr" rid="r26">26</xref>] we used the candidate gene approach to evaluate <italic>PAX6</italic> in the study population. <italic>PAX6</italic> was cloned from a canine retinal cDNA library, and linked to WT1 and Wilms-TF on CFA18 using an RH3000 panel. A previous study placed <italic>PAX6</italic> on CFA18 in the same region between markers FH3824 and CFOR04B04 using an RH5000 panel [<xref ref-type="bibr" rid="r27">27</xref>]. WT1 is just 4 cRays away from marker FH3824, and 14 cRays from CFOR04B04 on the RH5000, 4249-marker map [<xref ref-type="bibr" rid="r25">25</xref>]. Integrated canine maps demonstrate homology between CFA18 and human chromosomes 7 and 11 [<xref ref-type="bibr" rid="r28">28</xref>-<xref ref-type="bibr" rid="r30">30</xref>]. <italic>PAX6</italic> is located in a region of CFA18 which has homology with human chromosome 11p13, where <italic>PAX6</italic> is located in man.</p><p>The canine <italic>PAX6</italic> cDNA sequence was 1,786 bp, and included predicted exons 1 and 2, and cloned exons 3-13, plus alternatively transcribed exon 5a (EF141016, EF141017). This cDNA has sequence identity with the current <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/cgi-bin/hgGateway">canine genomic sequence</ext-link> over a span &#x0003e;21 kb in length (38,671,042-38,692,610) [<xref ref-type="bibr" rid="r17">17</xref>]. This presumably represents the genomic length of the canine <italic>PAX6</italic> gene. The human <italic>PAX6</italic> genomic sequence is 22.4kb (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_001604">NM_001604</ext-link>), while the mouse genomic sequence is 20.6kb (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_013627">NM_013627</ext-link>). Canine <italic>PAX6</italic> exons 3-4 and 9-13 matched sequences in the current genomic sequence. However, exons 1-2 fell within a 714 bp gap, and exons 5-8 fell within a second 12,622 bp gap in the sequence. The exons that are missing in the current draft canine genomic sequence are provided by our cloning studies. Thus, this study fills in the gaps left by the draft canine genome sequence, and provides a complete canine <italic>PAX6</italic> sequence.</p><p>At the nucleotide level, the canine <italic>PAX6(5a)</italic> coding sequence (1,311 bp) had a higher degree of homology to the human (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_001604">NM_001604</ext-link>; 97.3% identical) than to the mouse (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_013627">NM_013627</ext-link>; 93.2% identical) sequence. Most of the nucleotide variations occurred within the PST domain: 26 of the 36 nucleotide differences between dog and human, and 50 of 89 differences between dog and mouse. Nevertheless, most of the nucleotide differences occurred in the third codon position and were synonymous changes which did not result in corresponding amino acid changes (<xref ref-type="fig" rid="f5">Figure 5</xref>).</p><p>At the amino acid level, canine PAX6 is 99.8% and 99.5% identical, respectively, to the human and murine sequences. The one amino acid difference between canine and human sequences occurred in the PST region at codon 405 (nucleotide position 1213, within the 1311 bp coding sequence) which codes for alanine in the dog, and threonine in man. The mouse also has threonine at codon 405, and, in addition, the mouse has glutamic acid in the PD at codon 60 (nucleotide position 178, within the 1311 bp coding sequence) while the dog and human have glutamine. The extremely high <italic>PAX6</italic> nucleotide and amino acid sequence identities between dog, man, and mouse suggest a consistency in protein structure and function.</p><p>Both canine (EF141016, EF141017) and human (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_001604">NM_001604</ext-link>) <italic>PAX6</italic> contained 13 exons plus an alternatively transcribed exon 5a. Exons 3-12 and intron 5a were the same sizes in both species while intronic sizes were similar. The mouse (<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/external.cgi?gbdna=NM_013627">NM_013627</ext-link>) gene, however, only has 12 exons (plus exon 4a) with mouse exons 2-12 corresponding to canine and human exons 3-13. The mouse coding sequence (exons 3-12) was the same size as the corresponding coding sequences in dog and human (exons 4-13). Mouse exon 2, and introns 1-12 were also similar in size to canine and human, but mouse exon 1 was 386 bp compared with 103 bp (dog) and 119 bp (human). Mouse exon 1 is more similar in size to canine and human exons 1 and 2 combined, 327 (canine) and 307 (human), and may explain why the mouse has one less exon than the canine and human genes.</p><p>No pathological mutations were detected in the canine <italic>PAX6</italic> coding sequence, non-coding exons, or in the intron/exon junctions of aniridia-affected dogs. This included coding exons 4-13, the alternatively transcribed exon 5a, and the non-coding exons 1-3 in the 5' UTR. Because the dogs used in this study were privately owned pets or working dogs, we were unable to obtain tissue samples to examine <italic>PAX6</italic> RNA products to detect splicing defects or other transcript variants. We also were unable to examine <italic>PAX6</italic> expression in normal and affected animals to rule out mutations in a promoter or enhancer.</p><p>Limitations in access to a larger sample size of dogs, or the ability to carry out prospective matings, prevented confirmation of the mode of inheritance of canine aniridia, and created difficulties in interpreting the association test. If canine aniridia is inherited as a recessive trait, the association test suggests no association of the <italic>PAX6</italic> locus with the aniridia phenotype. However, if canine aniridia is a dominant disease, there appears to be association of <italic>PAX6</italic> with aniridia in that all affected dogs share at least one common haplotype ("111TG1"). Dominance with incomplete penetrance could account for the presence of this common haplotype in the "non-affected" dogs (GD2, GD3, GD8, and GD13). Nonetheless, the broadly similar aniridia phenotype present in dogs homozygous or heterozygous for the "111TG1" haplotype argues against dominant inheritance. This emphasizes the need for further analysis of animals to establish the mode of inheritance, and to conduct a more complete association test and segregation analysis.</p><p>Regardless of the mode of inheritance, the Southern blot analysis showed no difference in normal from affected dogs using both a 5' and a 3' end probe which ruled out a large deletion in the <italic>PAX6</italic> gene. In the case of a recessively inherited deletion, normal and affected dogs would be distinguishable on Southern analysis because all affected dogs would be homozygous and have either no <italic>PAX6</italic> band (if the probe is in the deletion), or a smaller <italic>PAX6</italic> band (if the probe is not in the deletion, and the deletion is greater than or equal to 50 bp). In the case of dominant inheritance, a large deletion in the <italic>PAX6</italic> gene may go undetected in a heterozygous-affected dog if the probe lies within the deletion. However, because we used both 5' and 3' end probes, we should detect a 5' end deletion with the 3' end probe and vise versa, unless the entire gene is deleted. We know that the entire gene is not deleted because of the heterozygosity detected in exon 7 (GD3, GD8, GD12, and GD13) and intron 8 (GD3 and GD8) SNPs. It is very unlikely that a genomic deletion that spares the exon 7 and intron 8 regions would also be unrecognizable using probes at both the 5' and 3' ends of the gene. As a result, we have excluded a large deletion in <italic>PAX6</italic> as a cause of aniridia in the Catalan sheep dog.</p></sec></body><back><ack><title>Acknowledgements</title><p>We would like to express our sincere thanks and appreciation to Vicki Meyers-Wallen, Anna Kukekova, James Kijas, Orly Goldstein, and Keith Watamura for their help, support and interest in this work. We would also like to thank Vicky Baldwin for laboratory assistance in cloning. Funding was provided by the National Institutes of Health (F32-EY13677, EY-06855, and EY-13132), Cornell University Graduate Research Assistantship, The Morris Animal Foundation, and the Van Sloan Fund for Canine Genetic Research.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sale</surname><given-names>MM</given-names></name><name><surname>Craig</surname><given-names>JE</given-names></name><name><surname>Charlesworth</surname><given-names>JC</given-names></name><name><surname>FitzGerald</surname><given-names>LM</given-names></name><name><surname>Hanson</surname><given-names>IM</given-names></name><name><surname>Dickinson</surname><given-names>JL</given-names></name><name><surname>Matthews</surname><given-names>SJ</given-names></name><name><surname>Heyningen Vv</surname><given-names>V</given-names></name><name><surname>Fingert</surname><given-names>JH</given-names></name><name><surname>Mackey</surname><given-names>DA</given-names></name></person-group><article-title>Broad phenotypic variability in a single pedigree with a novel 1410delC mutation in the PST domain of the PAX6 gene.</article-title><source>Hum Mutat</source><year>2002</year><volume>20</volume><fpage>322</fpage><pub-id pub-id-type="pmid">12325030</pub-id></citation></ref><ref id="r2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hodgson</surname><given-names>SV</given-names></name><name><surname>Saunders</surname><given-names>KE</given-names></name></person-group><article-title>A probable case of the homozygous condition of the aniridia gene.</article-title><source>J Med Genet</source><year>1980</year><volume>17</volume><fpage>478</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">6782213</pub-id></citation></ref><ref id="r3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glaser</surname><given-names>T</given-names></name><name><surname>Jepeal</surname><given-names>L</given-names></name><name><surname>Edwards</surname><given-names>JG</given-names></name><name><surname>Young</surname><given-names>SR</given-names></name><name><surname>Favor</surname><given-names>J</given-names></name><name><surname>Maas</surname><given-names>RL</given-names></name></person-group><article-title>PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects.</article-title><source>Nat Genet</source><year>1994</year><volume>7</volume><fpage>463</fpage><lpage>71</lpage><comment>Erratum in: Nat Genet 1994; 8:203</comment><pub-id pub-id-type="pmid">7951315</pub-id></citation></ref><ref id="r4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walther</surname><given-names>C</given-names></name><name><surname>Gruss</surname><given-names>P</given-names></name></person-group><article-title>Pax-6, a murine paired box gene, is expressed in the developing CNS.</article-title><source>Development</source><year>1991</year><volume>113</volume><fpage>1435</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">1687460</pub-id></citation></ref><ref id="r5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ton</surname><given-names>CC</given-names></name><name><surname>Hirvonen</surname><given-names>H</given-names></name><name><surname>Miwa</surname><given-names>H</given-names></name><name><surname>Weil</surname><given-names>MM</given-names></name><name><surname>Monaghan</surname><given-names>P</given-names></name><name><surname>Jordan</surname><given-names>T</given-names></name><name><surname>van Heyningen</surname><given-names>V</given-names></name><name><surname>Hastie</surname><given-names>ND</given-names></name><name><surname>Meijers-Heijboer</surname><given-names>H</given-names></name><name><surname>Drechsler</surname><given-names>M</given-names></name><name><surname>Royer-Pokora</surname><given-names>B</given-names></name><name><surname>Collins</surname><given-names>F</given-names></name><name><surname>Swaroop</surname><given-names>A</given-names></name><name><surname>Strong</surname><given-names>LC</given-names></name><name><surname>Saunders</surname><given-names>GF</given-names></name></person-group><article-title>Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region.</article-title><source>Cell</source><year>1991</year><volume>67</volume><fpage>1059</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">1684738</pub-id></citation></ref><ref id="r6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ton</surname><given-names>CC</given-names></name><name><surname>Miwa</surname><given-names>H</given-names></name><name><surname>Saunders</surname><given-names>GF</given-names></name></person-group><article-title>Small eye (Sey): cloning and characterization of the murine homolog of the human aniridia gene.</article-title><source>Genomics</source><year>1992</year><volume>13</volume><fpage>251</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">1612585</pub-id></citation></ref><ref id="r7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gerard</surname><given-names>M</given-names></name><name><surname>Abitbol</surname><given-names>M</given-names></name><name><surname>Delezoide</surname><given-names>AL</given-names></name><name><surname>Dufier</surname><given-names>JL</given-names></name><name><surname>Mallet</surname><given-names>J</given-names></name><name><surname>Vekemans</surname><given-names>M</given-names></name></person-group><article-title>PAX-genes expression during human embryonic development, a preliminary report.</article-title><source>C R Acad Sci III</source><year>1995</year><volume>318</volume><fpage>57</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">7757805</pub-id></citation></ref><ref id="r8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grindley</surname><given-names>JC</given-names></name><name><surname>Davidson</surname><given-names>DR</given-names></name><name><surname>Hill</surname><given-names>RE</given-names></name></person-group><article-title>The role of Pax-6 in eye and nasal development.</article-title><source>Development</source><year>1995</year><volume>121</volume><fpage>1433</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">7789273</pub-id></citation></ref><ref id="r9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Halder</surname><given-names>G</given-names></name><name><surname>Callaerts</surname><given-names>P</given-names></name><name><surname>Gehring</surname><given-names>WJ</given-names></name></person-group><article-title>Induction of ectopic eyes by targeted expression of the eyeless gene in Drosophila.</article-title><source>Science</source><year>1995</year><volume>267</volume><fpage>1788</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">7892602</pub-id></citation></ref><ref id="r10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>RL</given-names></name><name><surname>Altmann</surname><given-names>CR</given-names></name><name><surname>Lang</surname><given-names>RA</given-names></name><name><surname>Hemmati-Brivanlou</surname><given-names>A</given-names></name></person-group><article-title>Pax6 induces ectopic eyes in a vertebrate.</article-title><source>Development</source><year>1999</year><volume>126</volume><fpage>4213</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">10477290</pub-id></citation></ref><ref id="r11"><label>11</label><citation citation-type="book">Lindsley DL, Zimm GG. The genome of Drosophila melanogaster. San Diego: Academic Press; 1992.</citation></ref><ref id="r12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>RE</given-names></name><name><surname>Favor</surname><given-names>J</given-names></name><name><surname>Hogan</surname><given-names>BL</given-names></name><name><surname>Ton</surname><given-names>CC</given-names></name><name><surname>Saunders</surname><given-names>GF</given-names></name><name><surname>Hanson</surname><given-names>IM</given-names></name><name><surname>Prosser</surname><given-names>J</given-names></name><name><surname>Jordan</surname><given-names>T</given-names></name><name><surname>Hastie</surname><given-names>ND</given-names></name><name><surname>van Heyningen</surname><given-names>V</given-names></name></person-group><article-title>Mouse small eye results from mutations in a paired-like homeobox-containing gene.</article-title><source>Nature</source><year>1991</year><volume>354</volume><fpage>522</fpage><lpage>5</lpage><comment>Erratum in: Nature. 1992; 355:750</comment><pub-id pub-id-type="pmid">1684639</pub-id></citation></ref><ref id="r13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Favor</surname><given-names>J</given-names></name><name><surname>Peters</surname><given-names>H</given-names></name><name><surname>Hermann</surname><given-names>T</given-names></name><name><surname>Schmahl</surname><given-names>W</given-names></name><name><surname>Chatterjee</surname><given-names>B</given-names></name><name><surname>Neuhauser-Klaus</surname><given-names>A</given-names></name><name><surname>Sandulache</surname><given-names>R</given-names></name></person-group><article-title>Molecular characterization of Pax6(2Neu) through Pax6(10Neu): an extension of the Pax6 allelic series and the identification of two possible hypomorph alleles in the mouse Mus musculus.</article-title><source>Genetics</source><year>2001</year><volume>159</volume><fpage>1689</fpage><lpage>700</lpage><pub-id pub-id-type="pmid">11779807</pub-id></citation></ref><ref id="r14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>JA</given-names></name><name><surname>Glaser</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Jepeal</surname><given-names>L</given-names></name><name><surname>Walton</surname><given-names>DS</given-names></name><name><surname>Maas</surname><given-names>RL</given-names></name></person-group><article-title>Two independent and interactive DNA-binding subdomains of the Pax6 paired domain are regulated by alternative splicing.</article-title><source>Genes Dev</source><year>1994</year><volume>8</volume><fpage>2022</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">7958875</pub-id></citation></ref><ref id="r15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Azuma</surname><given-names>N</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Handa</surname><given-names>H</given-names></name><name><surname>Hayakawa</surname><given-names>M</given-names></name><name><surname>Kanai</surname><given-names>A</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name></person-group><article-title>Missense mutation in the alternative splice region of the PAX6 gene in eye anomalies.</article-title><source>Am J Hum Genet</source><year>1999</year><volume>65</volume><fpage>656</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">10441571</pub-id></citation></ref><ref id="r16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Sawada</surname><given-names>J</given-names></name><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Handa</surname><given-names>H</given-names></name><name><surname>Azuma</surname><given-names>N</given-names></name></person-group><article-title>Autoregulation of Pax6 transcriptional activation by two distinct DNA-binding subdomains of the paired domain.</article-title><source>Genes Cells</source><year>1997</year><volume>2</volume><fpage>255</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">9224659</pub-id></citation></ref><ref id="r17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindblad-Toh</surname><given-names>K</given-names></name><name><surname>Wade</surname><given-names>CM</given-names></name><name><surname>Mikkelsen</surname><given-names>TS</given-names></name><name><surname>Karlsson</surname><given-names>EK</given-names></name><name><surname>Jaffe</surname><given-names>DB</given-names></name><name><surname>Kamal</surname><given-names>M</given-names></name><name><surname>Clamp</surname><given-names>M</given-names></name><name><surname>Chang</surname><given-names>JL</given-names></name><name><surname>Kulbokas</surname><given-names>EJ</given-names><suffix>3rd</suffix></name><name><surname>Zody</surname><given-names>MC</given-names></name><name><surname>Mauceli</surname><given-names>E</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Breen</surname><given-names>M</given-names></name><name><surname>Wayne</surname><given-names>RK</given-names></name><name><surname>Ostrander</surname><given-names>EA</given-names></name><name><surname>Ponting</surname><given-names>CP</given-names></name><name><surname>Galibert</surname><given-names>F</given-names></name><name><surname>Smith</surname><given-names>DR</given-names></name><name><surname>DeJong</surname><given-names>PJ</given-names></name><name><surname>Kirkness</surname><given-names>E</given-names></name><name><surname>Alvarez</surname><given-names>P</given-names></name><name><surname>Biagi</surname><given-names>T</given-names></name><name><surname>Brockman</surname><given-names>W</given-names></name><name><surname>Butler</surname><given-names>J</given-names></name><name><surname>Chin</surname><given-names>CW</given-names></name><name><surname>Cook</surname><given-names>A</given-names></name><name><surname>Cuff</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>DeCaprio</surname><given-names>D</given-names></name><name><surname>Gnerre</surname><given-names>S</given-names></name><name><surname>Grabherr</surname><given-names>M</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Kleber</surname><given-names>M</given-names></name><name><surname>Bardeleben</surname><given-names>C</given-names></name><name><surname>Goodstadt</surname><given-names>L</given-names></name><name><surname>Heger</surname><given-names>A</given-names></name><name><surname>Hitte</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>L</given-names></name><name><surname>Koepfli</surname><given-names>KP</given-names></name><name><surname>Parker</surname><given-names>HG</given-names></name><name><surname>Pollinger</surname><given-names>JP</given-names></name><name><surname>Searle</surname><given-names>SM</given-names></name><name><surname>Sutter</surname><given-names>NB</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Webber</surname><given-names>C</given-names></name><name><surname>Baldwin</surname><given-names>J</given-names></name><name><surname>Abebe</surname><given-names>A</given-names></name><name><surname>Abouelleil</surname><given-names>A</given-names></name><name><surname>Aftuck</surname><given-names>L</given-names></name><name><surname>Ait-Zahra</surname><given-names>M</given-names></name><name><surname>Aldredge</surname><given-names>T</given-names></name><name><surname>Allen</surname><given-names>N</given-names></name><name><surname>An</surname><given-names>P</given-names></name><name><surname>Anderson</surname><given-names>S</given-names></name><name><surname>Antoine</surname><given-names>C</given-names></name><name><surname>Arachchi</surname><given-names>H</given-names></name><name><surname>Aslam</surname><given-names>A</given-names></name><name><surname>Ayotte</surname><given-names>L</given-names></name><name><surname>Bachantsang</surname><given-names>P</given-names></name><name><surname>Barry</surname><given-names>A</given-names></name><name><surname>Bayul</surname><given-names>T</given-names></name><name><surname>Benamara</surname><given-names>M</given-names></name><name><surname>Berlin</surname><given-names>A</given-names></name><name><surname>Bessette</surname><given-names>D</given-names></name><name><surname>Blitshteyn</surname><given-names>B</given-names></name><name><surname>Bloom</surname><given-names>T</given-names></name><name><surname>Blye</surname><given-names>J</given-names></name><name><surname>Boguslavskiy</surname><given-names>L</given-names></name><name><surname>Bonnet</surname><given-names>C</given-names></name><name><surname>Boukhgalter</surname><given-names>B</given-names></name><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Cahill</surname><given-names>P</given-names></name><name><surname>Calixte</surname><given-names>N</given-names></name><name><surname>Camarata</surname><given-names>J</given-names></name><name><surname>Cheshatsang</surname><given-names>Y</given-names></name><name><surname>Chu</surname><given-names>J</given-names></name><name><surname>Citroen</surname><given-names>M</given-names></name><name><surname>Collymore</surname><given-names>A</given-names></name><name><surname>Cooke</surname><given-names>P</given-names></name><name><surname>Dawoe</surname><given-names>T</given-names></name><name><surname>Daza</surname><given-names>R</given-names></name><name><surname>Decktor</surname><given-names>K</given-names></name><name><surname>DeGray</surname><given-names>S</given-names></name><name><surname>Dhargay</surname><given-names>N</given-names></name><name><surname>Dooley</surname><given-names>K</given-names></name><name><surname>Dooley</surname><given-names>K</given-names></name><name><surname>Dorje</surname><given-names>P</given-names></name><name><surname>Dorjee</surname><given-names>K</given-names></name><name><surname>Dorris</surname><given-names>L</given-names></name><name><surname>Duffey</surname><given-names>N</given-names></name><name><surname>Dupes</surname><given-names>A</given-names></name><name><surname>Egbiremolen</surname><given-names>O</given-names></name><name><surname>Elong</surname><given-names>R</given-names></name><name><surname>Falk</surname><given-names>J</given-names></name><name><surname>Farina</surname><given-names>A</given-names></name><name><surname>Faro</surname><given-names>S</given-names></name><name><surname>Ferguson</surname><given-names>D</given-names></name><name><surname>Ferreira</surname><given-names>P</given-names></name><name><surname>Fisher</surname><given-names>S</given-names></name><name><surname>FitzGerald</surname><given-names>M</given-names></name><name><surname>Foley</surname><given-names>K</given-names></name><name><surname>Foley</surname><given-names>C</given-names></name><name><surname>Franke</surname><given-names>A</given-names></name><name><surname>Friedrich</surname><given-names>D</given-names></name><name><surname>Gage</surname><given-names>D</given-names></name><name><surname>Garber</surname><given-names>M</given-names></name><name><surname>Gearin</surname><given-names>G</given-names></name><name><surname>Giannoukos</surname><given-names>G</given-names></name><name><surname>Goode</surname><given-names>T</given-names></name><name><surname>Goyette</surname><given-names>A</given-names></name><name><surname>Graham</surname><given-names>J</given-names></name><name><surname>Grandbois</surname><given-names>E</given-names></name><name><surname>Gyaltsen</surname><given-names>K</given-names></name><name><surname>Hafez</surname><given-names>N</given-names></name><name><surname>Hagopian</surname><given-names>D</given-names></name><name><surname>Hagos</surname><given-names>B</given-names></name><name><surname>Hall</surname><given-names>J</given-names></name><name><surname>Healy</surname><given-names>C</given-names></name><name><surname>Hegarty</surname><given-names>R</given-names></name><name><surname>Honan</surname><given-names>T</given-names></name><name><surname>Horn</surname><given-names>A</given-names></name><name><surname>Houde</surname><given-names>N</given-names></name><name><surname>Hughes</surname><given-names>L</given-names></name><name><surname>Hunnicutt</surname><given-names>L</given-names></name><name><surname>Husby</surname><given-names>M</given-names></name><name><surname>Jester</surname><given-names>B</given-names></name><name><surname>Jones</surname><given-names>C</given-names></name><name><surname>Kamat</surname><given-names>A</given-names></name><name><surname>Kanga</surname><given-names>B</given-names></name><name><surname>Kells</surname><given-names>C</given-names></name><name><surname>Khazanovich</surname><given-names>D</given-names></name><name><surname>Kieu</surname><given-names>AC</given-names></name><name><surname>Kisner</surname><given-names>P</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Lance</surname><given-names>K</given-names></name><name><surname>Landers</surname><given-names>T</given-names></name><name><surname>Lara</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>W</given-names></name><name><surname>Leger</surname><given-names>JP</given-names></name><name><surname>Lennon</surname><given-names>N</given-names></name><name><surname>Leuper</surname><given-names>L</given-names></name><name><surname>LeVine</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Lokyitsang</surname><given-names>Y</given-names></name><name><surname>Lokyitsang</surname><given-names>T</given-names></name><name><surname>Lui</surname><given-names>A</given-names></name><name><surname>Macdonald</surname><given-names>J</given-names></name><name><surname>Major</surname><given-names>J</given-names></name><name><surname>Marabella</surname><given-names>R</given-names></name><name><surname>Maru</surname><given-names>K</given-names></name><name><surname>Matthews</surname><given-names>C</given-names></name><name><surname>McDonough</surname><given-names>S</given-names></name><name><surname>Mehta</surname><given-names>T</given-names></name><name><surname>Meldrim</surname><given-names>J</given-names></name><name><surname>Melnikov</surname><given-names>A</given-names></name><name><surname>Meneus</surname><given-names>L</given-names></name><name><surname>Mihalev</surname><given-names>A</given-names></name><name><surname>Mihova</surname><given-names>T</given-names></name><name><surname>Miller</surname><given-names>K</given-names></name><name><surname>Mittelman</surname><given-names>R</given-names></name><name><surname>Mlenga</surname><given-names>V</given-names></name><name><surname>Mulrain</surname><given-names>L</given-names></name><name><surname>Munson</surname><given-names>G</given-names></name><name><surname>Navidi</surname><given-names>A</given-names></name><name><surname>Naylor</surname><given-names>J</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Nguyen</surname><given-names>N</given-names></name><name><surname>Nguyen</surname><given-names>C</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Nicol</surname><given-names>R</given-names></name><name><surname>Norbu</surname><given-names>N</given-names></name><name><surname>Norbu</surname><given-names>C</given-names></name><name><surname>Novod</surname><given-names>N</given-names></name><name><surname>Nyima</surname><given-names>T</given-names></name><name><surname>Olandt</surname><given-names>P</given-names></name><name><surname>O'Neill</surname><given-names>B</given-names></name><name><surname>O'Neill</surname><given-names>K</given-names></name><name><surname>Osman</surname><given-names>S</given-names></name><name><surname>Oyono</surname><given-names>L</given-names></name><name><surname>Patti</surname><given-names>C</given-names></name><name><surname>Perrin</surname><given-names>D</given-names></name><name><surname>Phunkhang</surname><given-names>P</given-names></name><name><surname>Pierre</surname><given-names>F</given-names></name><name><surname>Priest</surname><given-names>M</given-names></name><name><surname>Rachupka</surname><given-names>A</given-names></name><name><surname>Raghuraman</surname><given-names>S</given-names></name><name><surname>Rameau</surname><given-names>R</given-names></name><name><surname>Ray</surname><given-names>V</given-names></name><name><surname>Raymond</surname><given-names>C</given-names></name><name><surname>Rege</surname><given-names>F</given-names></name><name><surname>Rise</surname><given-names>C</given-names></name><name><surname>Rogers</surname><given-names>J</given-names></name><name><surname>Rogov</surname><given-names>P</given-names></name><name><surname>Sahalie</surname><given-names>J</given-names></name><name><surname>Settipalli</surname><given-names>S</given-names></name><name><surname>Sharpe</surname><given-names>T</given-names></name><name><surname>Shea</surname><given-names>T</given-names></name><name><surname>Sheehan</surname><given-names>M</given-names></name><name><surname>Sherpa</surname><given-names>N</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Shih</surname><given-names>D</given-names></name><name><surname>Sloan</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>C</given-names></name><name><surname>Sparrow</surname><given-names>T</given-names></name><name><surname>Stalker</surname><given-names>J</given-names></name><name><surname>Stange-Thomann</surname><given-names>N</given-names></name><name><surname>Stavropoulos</surname><given-names>S</given-names></name><name><surname>Stone</surname><given-names>C</given-names></name><name><surname>Stone</surname><given-names>S</given-names></name><name><surname>Sykes</surname><given-names>S</given-names></name><name><surname>Tchuinga</surname><given-names>P</given-names></name><name><surname>Tenzing</surname><given-names>P</given-names></name><name><surname>Tesfaye</surname><given-names>S</given-names></name><name><surname>Thoulutsang</surname><given-names>D</given-names></name><name><surname>Thoulutsang</surname><given-names>Y</given-names></name><name><surname>Topham</surname><given-names>K</given-names></name><name><surname>Topping</surname><given-names>I</given-names></name><name><surname>Tsamla</surname><given-names>T</given-names></name><name><surname>Vassiliev</surname><given-names>H</given-names></name><name><surname>Venkataraman</surname><given-names>V</given-names></name><name><surname>Vo</surname><given-names>A</given-names></name><name><surname>Wangchuk</surname><given-names>T</given-names></name><name><surname>Wangdi</surname><given-names>T</given-names></name><name><surname>Weiand</surname><given-names>M</given-names></name><name><surname>Wilkinson</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>A</given-names></name><name><surname>Yadav</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Young</surname><given-names>G</given-names></name><name><surname>Yu</surname><given-names>Q</given-names></name><name><surname>Zainoun</surname><given-names>J</given-names></name><name><surname>Zembek</surname><given-names>L</given-names></name><name><surname>Zimmer</surname><given-names>A</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name></person-group><article-title>Genome sequence, comparative analysis and haplotype structure of the domestic dog.</article-title><source>Nature</source><year>2005</year><volume>438</volume><fpage>803</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">16341006</pub-id></citation></ref><ref id="r18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villagrasa</surname><given-names>M</given-names></name></person-group><article-title>Aplasia-hipoplasia de iris con car&#x000e1;cter hereditario en el gos d'atura.</article-title><source>Clinica Veterinaria de Peque&#x000f1;os Animales</source><year>1996</year><volume>16</volume><fpage>201</fpage><lpage>5</lpage></citation></ref><ref id="r19"><label>19</label><citation citation-type="book">Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor (NY): Cold Spring Harbor Press; 1989.</citation></ref><ref id="r20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirkness</surname><given-names>EF</given-names></name><name><surname>Bafna</surname><given-names>V</given-names></name><name><surname>Halpern</surname><given-names>AL</given-names></name><name><surname>Levy</surname><given-names>S</given-names></name><name><surname>Remington</surname><given-names>K</given-names></name><name><surname>Rusch</surname><given-names>DB</given-names></name><name><surname>Delcher</surname><given-names>AL</given-names></name><name><surname>Pop</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Fraser</surname><given-names>CM</given-names></name><name><surname>Venter</surname><given-names>JC</given-names></name></person-group><article-title>The dog genome: survey sequencing and comparative analysis.</article-title><source>Science</source><year>2003</year><volume>301</volume><fpage>1898</fpage><lpage>903</lpage><pub-id pub-id-type="pmid">14512627</pub-id></citation></ref><ref id="r21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mellersh</surname><given-names>CS</given-names></name><name><surname>Hitte</surname><given-names>C</given-names></name><name><surname>Richman</surname><given-names>M</given-names></name><name><surname>Vignaux</surname><given-names>F</given-names></name><name><surname>Priat</surname><given-names>C</given-names></name><name><surname>Jouquand</surname><given-names>S</given-names></name><name><surname>Werner</surname><given-names>P</given-names></name><name><surname>Andre</surname><given-names>C</given-names></name><name><surname>DeRose</surname><given-names>S</given-names></name><name><surname>Patterson</surname><given-names>DF</given-names></name><name><surname>Ostrander</surname><given-names>EA</given-names></name><name><surname>Galibert</surname><given-names>F</given-names></name></person-group><article-title>An integrated linkage-radiation hybrid map of the canine genome.</article-title><source>Mamm Genome</source><year>2000</year><volume>11</volume><fpage>120</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">10656926</pub-id></citation></ref><ref id="r22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Breen</surname><given-names>M</given-names></name><name><surname>Jouquand</surname><given-names>S</given-names></name><name><surname>Renier</surname><given-names>C</given-names></name><name><surname>Mellersh</surname><given-names>CS</given-names></name><name><surname>Hitte</surname><given-names>C</given-names></name><name><surname>Holmes</surname><given-names>NG</given-names></name><name><surname>Cheron</surname><given-names>A</given-names></name><name><surname>Suter</surname><given-names>N</given-names></name><name><surname>Vignaux</surname><given-names>F</given-names></name><name><surname>Bristow</surname><given-names>AE</given-names></name><name><surname>Priat</surname><given-names>C</given-names></name><name><surname>McCann</surname><given-names>E</given-names></name><name><surname>Andre</surname><given-names>C</given-names></name><name><surname>Boundy</surname><given-names>S</given-names></name><name><surname>Gitsham</surname><given-names>P</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Bridge</surname><given-names>WL</given-names></name><name><surname>Spriggs</surname><given-names>HF</given-names></name><name><surname>Ryder</surname><given-names>EJ</given-names></name><name><surname>Curson</surname><given-names>A</given-names></name><name><surname>Sampson</surname><given-names>J</given-names></name><name><surname>Ostrander</surname><given-names>EA</given-names></name><name><surname>Binns</surname><given-names>MM</given-names></name><name><surname>Galibert</surname><given-names>F</given-names></name></person-group><article-title>Chromosome-specific single-locus FISH probes allow anchorage of an 1800-marker integrated radiation-hybrid/linkage map of the domestic dog genome to all chromosomes.</article-title><source>Genome Res</source><year>2001</year><volume>11</volume><fpage>1784</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">11591656</pub-id></citation></ref><ref id="r23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matise</surname><given-names>TC</given-names></name><name><surname>Perlin</surname><given-names>M</given-names></name><name><surname>Chakravarti</surname><given-names>A</given-names></name></person-group><article-title>Automated construction of genetic linkage maps using an expert system (MultiMap): a human genome linkage map.</article-title><source>Nat Genet</source><year>1994</year><volume>6</volume><fpage>384</fpage><lpage>90</lpage><comment>Erratum in: Nat Genet 1994; 7:215</comment><pub-id pub-id-type="pmid">8054979</pub-id></citation></ref><ref id="r24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guyon</surname><given-names>R</given-names></name><name><surname>Lorentzen</surname><given-names>TD</given-names></name><name><surname>Hitte</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>L</given-names></name><name><surname>Cadieu</surname><given-names>E</given-names></name><name><surname>Parker</surname><given-names>HG</given-names></name><name><surname>Quignon</surname><given-names>P</given-names></name><name><surname>Lowe</surname><given-names>JK</given-names></name><name><surname>Renier</surname><given-names>C</given-names></name><name><surname>Gelfenbeyn</surname><given-names>B</given-names></name><name><surname>Vignaux</surname><given-names>F</given-names></name><name><surname>DeFrance</surname><given-names>HB</given-names></name><name><surname>Gloux</surname><given-names>S</given-names></name><name><surname>Mahairas</surname><given-names>GG</given-names></name><name><surname>Andre</surname><given-names>C</given-names></name><name><surname>Galibert</surname><given-names>F</given-names></name><name><surname>Ostrander</surname><given-names>EA</given-names></name></person-group><article-title>A 1-Mb resolution radiation hybrid map of the canine genome.</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>5296</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">12700351</pub-id></citation></ref><ref id="r25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Breen</surname><given-names>M</given-names></name><name><surname>Hitte</surname><given-names>C</given-names></name><name><surname>Lorentzen</surname><given-names>TD</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Cadieu</surname><given-names>E</given-names></name><name><surname>Sabacan</surname><given-names>L</given-names></name><name><surname>Scott</surname><given-names>A</given-names></name><name><surname>Evanno</surname><given-names>G</given-names></name><name><surname>Parker</surname><given-names>HG</given-names></name><name><surname>Kirkness</surname><given-names>EF</given-names></name><name><surname>Hudson</surname><given-names>R</given-names></name><name><surname>Guyon</surname><given-names>R</given-names></name><name><surname>Mahairas</surname><given-names>GG</given-names></name><name><surname>Gelfenbeyn</surname><given-names>B</given-names></name><name><surname>Fraser</surname><given-names>CM</given-names></name><name><surname>Andre</surname><given-names>C</given-names></name><name><surname>Galibert</surname><given-names>F</given-names></name><name><surname>Ostrander</surname><given-names>EA</given-names></name></person-group><article-title>An integrated 4249 marker FISH/RH map of the canine genome.</article-title><source>BMC Genomics</source><year>2004</year><volume>5</volume><fpage>65</fpage><pub-id pub-id-type="pmid">15363096</pub-id></citation></ref><ref id="r26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prosser</surname><given-names>J</given-names></name><name><surname>van Heyningen</surname><given-names>V</given-names></name></person-group><article-title>PAX6 mutations reviewed.</article-title><source>Hum Mutat</source><year>1998</year><volume>11</volume><fpage>93</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">9482572</pub-id></citation></ref><ref id="r27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>LS</given-names></name><name><surname>Sidjanin</surname><given-names>DJ</given-names></name><name><surname>Johnson</surname><given-names>JL</given-names></name><name><surname>Zangerl</surname><given-names>B</given-names></name><name><surname>Galibert</surname><given-names>F</given-names></name><name><surname>Andre</surname><given-names>C</given-names></name><name><surname>Kirkness</surname><given-names>E</given-names></name><name><surname>Talamas</surname><given-names>E</given-names></name><name><surname>Acland</surname><given-names>GM</given-names></name><name><surname>Aguirre</surname><given-names>GD</given-names></name></person-group><article-title>Radiation hybrid mapping of cataract genes in the dog.</article-title><source>Mol Vis</source><year>2006</year><volume>12</volume><fpage>588</fpage><lpage>96</lpage><ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/v12/a65/">http://www.molvis.org/molvis/v12/a65/</ext-link><pub-id pub-id-type="pmid">16760895</pub-id></citation></ref><ref id="r28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Breen</surname><given-names>M</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Binns</surname><given-names>MM</given-names></name><name><surname>Carter</surname><given-names>NP</given-names></name><name><surname>Langford</surname><given-names>CF</given-names></name></person-group><article-title>Reciprocal chromosome painting reveals detailed regions of conserved synteny between the karyotypes of the domestic dog (Canis familiaris) and human.</article-title><source>Genomics</source><year>1999</year><volume>61</volume><fpage>145</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">10534400</pub-id></citation></ref><ref id="r29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>O'Brien</surname><given-names>PC</given-names></name><name><surname>Milne</surname><given-names>BS</given-names></name><name><surname>Graphodatsky</surname><given-names>AS</given-names></name><name><surname>Solanky</surname><given-names>N</given-names></name><name><surname>Trifonov</surname><given-names>V</given-names></name><name><surname>Rens</surname><given-names>W</given-names></name><name><surname>Sargan</surname><given-names>D</given-names></name><name><surname>Ferguson-Smith</surname><given-names>MA</given-names></name></person-group><article-title>A complete comparative chromosome map for the dog, red fox, and human and its integration with canine genetic maps.</article-title><source>Genomics</source><year>1999</year><volume>62</volume><fpage>189</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">10610712</pub-id></citation></ref><ref id="r30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sargan</surname><given-names>DR</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Squire</surname><given-names>M</given-names></name><name><surname>Milne</surname><given-names>BS</given-names></name><name><surname>O'Brien</surname><given-names>PC</given-names></name><name><surname>Ferguson-Smith</surname><given-names>MA</given-names></name></person-group><article-title>Use of flow-sorted canine chromosomes in the assignment of canine linkage, radiation hybrid, and syntenic groups to chromosomes: refinement and verification of the comparative chromosome map for dog and human.</article-title><source>Genomics</source><year>2000</year><volume>69</volume><fpage>182</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">11031101</pub-id></citation></ref></ref-list></back></article> 